An AHA blog examines new data released by the Health Resources and Services Administration on the growth of the 340B Drug ...
Recent data released by the Health Resources and Services Administration show that drug purchases made under the 340B Drug Pricing Program totaled $81.4 billion in 2024.
HRS/ACC statement guides expanded access for intracardiac ablation procedures in ambulatory surgical centers for appropriate patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback